TUTOMESH
Report
- Report Number
- 3002924436-2025-00003
- Event Type
- Injury
- Date Received
- March 11, 2025
- Report Date
- April 24, 2025
- Manufacturer
- TUTOGEN MEDICAL GMBH
- Product Code
- FTM
- PMA / PMN Number
- K081538
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- DA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
AS NO UNIQUE IDENTIFIERS WERE PROVIDED TUTOGEN MEDICAL GMBH (TMI) WAS UNABLE TO CONDUCT A RECORDS REVIEW. THE AUTHOR WAS CONTACTED AND NO FURTHER DETAILS WILL BE PROVIDED, HOWEVER, IT WAS CONFIRMED THAT NO ADVERSE EFFECTS WERE FILED FOR THE STUDY. CAUSALITY ASSESSMENT FOR THE INDIVIDUAL COMPLICATIONS FOR TUTOMESH WAS REPORTED AS NOT RELATED (NO ADVERSE EFFECTS) BY THE AUTHOR AND FOR OVERALL CONCLUSION, THE USE OF TUTOMESH WAS DESCRIBED AS A SAFE METHOD IN THE ARTICLE. THE MENTIONED COMPLICATIONS REFLECT TYPICAL ADVERSE OCCURRENCES AFTER BREAST RECONSTRUCTION AND MAY ALSO BE CAUSED BY THE SURGICAL PROCEDURE. THEREFORE, TUTOGEN CONCURS WITH THE REPORTER AND CONSIDERS THESE EVENTS AS NOT RELATED.
NO PRODUCT IDENTIFIERS WERE PROVIDED. TUTOGEN MEDICAL GMBH WILL REQUEST ADDITIONAL INFORMATION. A FOLLOW-UP REPORT WILL BE SUBMITTED ONCE THIS INFORMATION IS AVAILABLE.
TUTOGEN MEDICAL GMBH (TMI), A WHOLLY SUBSIDIARY OF RTI SURGICAL INC INITIATED A COMPLAINT AS A RESULT OF A LITERATURE RESEARCH: IMMEDIATE PREFECTORAL BREAST RECONSTRUCTION USING BOVINE PERICARDIUM MATRIX. BENTZON TT ET. AL., DAN MED J 2025;72(2): A08240522. DOI: 1 0.61409/A08240522. THE PUBLICATION PROVIDES THE RESULTS OF A RETROSPECTIVE STUDY ON IMMEDIATE IMPLANT-BASED BREAST RECONSTRUCTION (IBBR) USING TUTOMESH AND LASER-ASSISTED INDOCYANINE GREEN ANGIOGRAPHY. EIGHTY ONE BREAST RECONSTRUCTIONS IN 56 PATIENTS WERE INCLUDED IN THE STUDY. THE FOLLOWING COMPLICATIONS WERE REPORTED: SKIN NECROSIS (5 EVENTS / 4 PATIENTS), INFECTION (3 EVENTS / 3 PATIENTS), HEMATOMA (2 EVENTS / 2 PATIENTS), WOUND DEHISCENCE (1 EVENT / 1 PATIENT), RIPPLING (11 EVENTS / 8 PATIENTS), BREAST IMPLANT ROTATION (6 EVENTS / 5 PATIENTS), AND BREAST IMPLANT LOSS (3 EVENTS / 3 PATIENTS). THE TOTAL COMPLICATION RATE WAS REPORTED AS 31 (38.2%) EVENTS AND 26 (46.6%) PATIENTS. PATIENT INDIVIDUAL DATA HAVE NOT BEEN PROVIDED TO TMI. ADDITIONALLY, A CAUSALITY ASSESSMENT REGARDING TUTOMESH WAS NOT PROVIDED. THE AUTHORS CONCLUDED THAT PREFECTORAL IBBR UTILIZING TUTOMESH IS A SAFE METHOD, WHICH YIELDS A GOOD AESTHETIC OUTCOME WITHOUT INCREASING THE RISK OF POST OPERATIVE COMPLICATIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1308834 | TUTOMESH | BOVINE PERICARDIUM | FTM | TUTOGEN MEDICAL GMBH |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Other |